Banner Default Image

Pharmacovigilance: in-house or outsource?

Back to events
20 October 2022 17:00-19:00 Register for Event

By 2025, the global pharmacovigilance (PV) market will likely have surpassed a value of $8.9 billion (Quanta, 2022). Pharma organisations have two choices: bring their pharmacovigilance teams in-house or outsource them. As a result, this has presented benefits and challenges on both sides, such as high costs, differences in quality and managing timelines and expectations.

Join us for our upcoming BioTalent Social webinar on 20th October, where we will address these factors while looking at how this can affect the UK market, as well as the importance of upskilling in the current climate.

Key topics of discussion will include:
o Outsourcing VS In-house
o Outsourcing to CROs within UK VS Outsourcing offshore
o Benefits and Challenges
o The implications of outsourcing on the UK market
o Importance of upskilling

Our panel:

  • Valerie Kalna - Host @ BioTalent Social

  • Nahed Souadkia - Pharmacovigilance Manager @ CLINUVEL

  • Tamara Herceg - PV Quality and Compliance Manager @ Aspen

  • Kieran O'Donnell - VP, Global Drug Safety @ Arriello

  • Dr Mahalakshmi Elluri - EU QPPV @ Amryt Pharma

Nahed Souadkia
Nahed is a Pharmacovigilance Manager at CLINUVEL and brings a wealth of knowledge and experience in Pharmacovigilance, as a Pharmacist and from her Research years. Nahed achieved a PhD in Pharmacy from the University of Nottingham in 2010, and worked as a pharmacist before moving into the Pharmacovigilance space, with a key focus on patient safety. In her spare time, Nahed enjoys hiking, crafts and baking.

Tamara Herceg
Tamara is a PV Quality and Compliance Manager at Aspen. Tamara completed her Master of economy at the University of Zagreb, Croatia and started postgraduate study of Health Management at Medical school of Zagreb, Croatia before moving to Dublin. Tamara has more than 25 years of experience in Pharmacovigilance from various perspectives. She worked at the National centre for ADRs at Clinical Hospital Center Zagreb, Section for clinical pharmacology and she moved from there to Croatian Agency for medicines and medical devices (HALMED) Pharmacovigilance department. She was developing her career in different pharmaceutical industries such as Pfizer, Roche, Aspen, and in CROs and Service providers. Tamara has also clinical trials experience and GCP certificate and she is a certified Lead GMP Auditor.

RSVP and save your spot now.

  • community-diversity-events
  • community-upcoming-events